These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11019725)

  • 1. Surfactant replacement therapy.
    Spragg RG
    Clin Chest Med; 2000 Sep; 21(3):531-41, ix. PubMed ID: 11019725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant therapy in adults with acute lung injury/acute respiratory distress syndrome.
    Kesecioglu J; Haitsma JJ
    Curr Opin Crit Care; 2006 Feb; 12(1):55-60. PubMed ID: 16394785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous surfactant in paediatric Acute Lung Injury and Acute Respiratory Distress Syndrome.
    Playfor SD; Nootigattu VK
    Curr Drug Saf; 2006 May; 1(2):159-68. PubMed ID: 18690927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of exogenous surfactant in the treatment of acute lung injury.
    Lewis JF; Veldhuizen R
    Annu Rev Physiol; 2003; 65():613-42. PubMed ID: 12517997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is surfactant a promising additive drug in ALI/ARDS-patients?
    Schultz MJ; Kesecioglu J
    Curr Drug Targets; 2004 Jul; 5(5):445-8. PubMed ID: 15216910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative computed tomography in porcine lung injury with variable versus conventional ventilation: recruitment and surfactant replacement.
    Ruth Graham M; Goertzen AL; Girling LG; Friedman T; Pauls RJ; Dickson T; Espenell AE; Mutch WA
    Crit Care Med; 2011 Jul; 39(7):1721-30. PubMed ID: 21460711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of surfactant therapy during ALI/ARDS.
    Lewis JF; Veldhuizen RA
    Semin Respir Crit Care Med; 2006 Aug; 27(4):377-88. PubMed ID: 16909371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rat model of acute respiratory distress syndrome (ARDS) Part 2, influence of lavage volume, lavage repetition, and therapeutic treatment with rSP-C surfactant.
    Häfner D; Germann PG
    J Pharmacol Toxicol Methods; 1999; 41(2-3):97-106. PubMed ID: 10598681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant supplementation in the lung.
    Anzueto A
    Respir Care Clin N Am; 2002 Jun; 8(2):211-36. PubMed ID: 12481816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant therapy for acute lung injury/acute respiratory distress syndrome.
    Haitsma JJ; Papadakos PJ; Lachmann B
    Curr Opin Crit Care; 2004 Feb; 10(1):18-22. PubMed ID: 15166845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of exogenous surfactant treatment in a murine model of two-hit lung injury.
    Zambelli V; Bellani G; Amigoni M; Grassi A; Scanziani M; Farina F; Latini R; Pesenti A
    Anesth Analg; 2015 Feb; 120(2):381-8. PubMed ID: 25502842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant treatment for congenital heart disease patients with acute respiratory distress syndrome.
    Alten JA; Borasino S; Pearce FB; Dabal RJ; Kirklin JK
    Congenit Heart Dis; 2010; 5(6):624-8. PubMed ID: 21106025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant replacement in neonatal and adult respiratory distress syndrome.
    Robertson B
    Eur J Anaesthesiol; 1984 Dec; 1(4):335-43. PubMed ID: 6549536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome.
    Spragg RG; Lewis JF; Walmrath HD; Johannigman J; Bellingan G; Laterre PF; Witte MC; Richards GA; Rippin G; Rathgeb F; Häfner D; Taut FJ; Seeger W
    N Engl J Med; 2004 Aug; 351(9):884-92. PubMed ID: 15329426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of ventilation-induced lung injury with exogenous surfactant.
    Vazquez de Anda GF; Lachmann RA; Gommers D; Verbrugge SJ; Haitsma J; Lachmann B
    Intensive Care Med; 2001 Mar; 27(3):559-65. PubMed ID: 11355126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models and clinical pilot studies of surfactant replacement in adult respiratory distress syndrome.
    Lachmann B
    Eur Respir J Suppl; 1989 Mar; 3():98s-103s. PubMed ID: 2663002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of surfactant replacement therapy in the treatment of acute respiratory distress syndrome].
    Lauer S; Fischer LG; Stubbe HD; Van Aken H; Westphal M
    Anaesthesist; 2006 Apr; 55(4):433-42. PubMed ID: 16440205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous surfactant therapy for ARDS.
    Maruscak A; Lewis JF
    Expert Opin Investig Drugs; 2006 Jan; 15(1):47-58. PubMed ID: 16370933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances with surfactant.
    Turell DC
    Emerg Med Clin North Am; 2008 Nov; 26(4):921-8, viii. PubMed ID: 19059091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanical ventilation and adjuncts in acute respiratory distress syndrome.
    Deb B; Pearl RG
    Int Anesthesiol Clin; 1997; 35(1):109-24. PubMed ID: 9113524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.